NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Profit & Loss Account Balance History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit & Loss Account Balance | ₹995 Cr | ₹752 Cr | ₹465 Cr | ₹308 Cr | ₹248 Cr |
What is the latest Profit & Loss Account Balance ratio of NEULAND LABORATORIES ?
| Year | Profit & Loss Account Balance |
|---|---|
| Mar2025 | ₹995 Cr |
| Mar2024 | ₹752 Cr |
| Mar2023 | ₹465 Cr |
| Mar2022 | ₹308 Cr |
| Mar2021 | ₹248 Cr |
How is Profit & Loss Account Balance of NEULAND LABORATORIES Trending?
| Years | Profit & Loss Account Balance | % Change | |
|---|---|---|---|
| Mar2025 | ₹995 Cr | 32.18 | |
| Mar2024 | ₹752 Cr | 61.74 | |
| Mar2023 | ₹465 Cr | 50.99 | |
| Mar2022 | ₹308 Cr | 24.17 | |
| Mar2021 | ₹248 Cr | - | |
Compare Profit & Loss Account Balance of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹21,745.3 Cr | 2.4% | -1.1% | -2.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹436,343.0 Cr | -0.2% | 5.8% | 0.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,774.0 Cr | -0.6% | -5.2% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹128,665.0 Cr | -0.5% | 2.5% | 12.1% | Stock Analytics | |
| CIPLA | ₹122,878.0 Cr | -1.1% | -0.2% | -1.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,581.0 Cr | 2.4% | 7% | 6.2% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | 2.4% |
-1.1% |
-2.1% |
| SENSEX | -0.5% |
1.5% |
6.9% |
You may also like the below Video Courses